Table 2.

Meta-Analysis Data

No. Study ID	Hazard ratio	95% Lower Confidence Limit	95% Upper Confidence Limit	Logn Hazard Ratio: Ln (hr)	Std Err	Year	Sample Size: patient users (N)
1. Ray* FGA	1.990	1.686	2.340	0.6881	0.085	2009	44,218
2. Ray* SGA	2.260	1.879	2.720	0.8154	0.094	2009	46,089
3. Rossom	1.674	1.062	2.637	0.5152	0.232	2010	18,127
4. Musicco FGA	3.700	2.600	5.100	1.3083	0.172	2011	156
5. Musicco SGA	2.500	2.033	3.100	0.9163	0.106	2011	806
6. Gisev	2.070	1.730	2.470	0.7280	0.091	2012	332
7. Gardette	1.930	1.148	3.245	0.6575	0.265	2012	102
8. Jones* FGA	2.340	2.281	2.401	0.8502	0.013	2013	115,491
9. Jones* SGA	1.760	1.711	1.811	0.5653	0.014	2013	67,901
10. Langballe	2.052	1.693	2.486	0.7188	0.098	2014	8,214
11. Piersanti SGA	2.354	1.697	3.265	0.8561	0.167	2014	375
12. Jennum FGA	1.292	1.218	1.366	0.2562	0.029	2015	259
13. Jennum SGA	1.442	1.400	1.484	0.3660	0.015	2015	832
14. Maust	1.688	1.370	2.090	0.5235	0.108	2015	14,788
15. Arai	1.675	0.900	3.118	0.5158	0.317	2016	4,873
16. Connors	1.610	1.290	2.020	0.4762	0.114	2016	779
17. Nielsen	2.310	2.142	2.492	0.8372	0.039	2017	16,976
18. Koponen	1.610	1.530	1.700	0.4762	0.027	2017	13,576
19. Martin-Arias*	2.030	1.760	2.330	0.7080	0.072	2017	5,206
20. Chiesa	1.570	0.945	2.607	0.4511	0.259	2017	135
						TOTAL	359,235

*values based on antipsychotic drug users in the general population.